Literature DB >> 28938419

Nocturnal Urinary Excretion of FSH and LH in Children and Adolescents With Normal and Early Puberty.

Nanna Kolby1,2, Alexander S Busch1,2, Lise Aksglaede1,2, Kaspar Sørensen1,2, Jorgen Holm Petersen1,2, Anna-Maria Andersson1,2, Anders Juul1,2.   

Abstract

Context: Clinical use of single serum gonadotropin measurements in children is limited by the pulsatile secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). However, first morning voided (FMV) urine may integrate the fluctuating gonadotropin serum levels. Objective: We aimed to evaluate urinary and serum gonadotropin levels according to age, sex, and pubertal stage in healthy children and to assess the clinical use of FMV urinary gonadotropins in children with disordered puberty. Design: Cross-sectional part of the COPENHAGEN Puberty Study and longitudinal study of patients. Setting: Population-based and outpatient clinic. Patients or Other Participants: Eight hundred forty-three healthy children from the COPENHAGEN Puberty Study and 25 girls evaluated for central precocious puberty (CPP). Main Outcome Measures: Clinical pubertal staging, including serum and urinary gonadotropin levels.
Results: Urinary gonadotropins increased with advancing age and pubertal development and were detectable in FMV urine before physical signs of puberty. FMV urinary LH correlated strongly with basal (r = 0.871, P < 0.001) and gonadotropin-releasing hormone (GnRH)-stimulated serum LH (r = 0.82, P < 0.001). Urinary LH was superior to urinary FSH in differentiating the pubertal stage. Receiver operating curve analysis revealed that a cut-off standard deviation (SD) score of 2 for urinary LH (IU/L) gave a sensitivity of 75% and a specificity of 92% in predicting a positive GnRH stimulation test (LHmax > 5 IU/L). Urinary concentrations of LH decreased after 3 months of GnRH treatment to levels below +2 SDs. Conclusions: Urinary gonadotropin levels increased before the onset of puberty and were elevated in girls with CPP. We suggest urinary LH as an alternative noninvasive method to improve diagnosing and therapeutic management of children with disordered puberty.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28938419     DOI: 10.1210/jc.2017-01192

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Urinary and salivary endocrine measurements to complement Tanner staging in studies of pubertal development.

Authors:  Mandy Goldberg; Anna J Ciesielski Jones; John A McGrath; Christie Barker-Cummings; Deborah S Cousins; Lauren M Kipling; Juliana W Meadows; James S Kesner; Michele Marcus; Carolyn Monteilh; Dale P Sandler
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS.

Authors:  Hanne Frederiksen; Trine Holm Johannsen; Stine Ehlern Andersen; Jakob Albrethsen; Selma Kløve Landersoe; Jørgen Holm Petersen; Anders Nyboe Andersen; Esben Thyssen Vestergaard; Mia Elbek Schorring; Allan Linneberg; Katharina M Main; Anna-Maria Andersson; Anders Juul
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

3.  The Role of Urinary LH and FSH in the Diagnosis of Pubertal Disorders.

Authors:  Manoranjan Tripathy; A K Baliarsinha; A K Choudhury; Upendra K Das
Journal:  Indian J Endocrinol Metab       Date:  2021-09-08

4.  The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis.

Authors:  Dan Xu; Xueying Zhou; Junfei Wang; Xi Cao; Tao Liu
Journal:  BMC Pediatr       Date:  2022-07-28       Impact factor: 2.567

5.  The Use of Morning Urinary Gonadotropins and Sex Hormones in the Management of Early Puberty in Chinese Girls.

Authors:  Shumin Zhan; Ke Huang; Wei Wu; Danni Zhang; Ana Liu; Robert M Dorazio; Jianrong Shi; Rahim Ullah; Li Zhang; Jinling Wang; Guanping Dong; Yan Ni; Junfen Fu
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.